Advanced Search

Journal of Traditional Chinese Medicine >

2023 , Vol. 43 >Issue 1: 134 - 139

DOI: https://doi.org/10.19852/j.cnki.jtcm.2023.01.012

Original articles

Effectiveness and safety of Jinshuibao capsules (金水宝胶囊) in treatment of residual cardiopulmonary symptoms in convalescent patients of coronavirus disease 2019: a pilot randomized, double-blind, placebo-controlled clinical trial

  • Yuehong ZHANG ,
  • Dandan DONG ,
  • Youqin YAN ,
  • Hao ZHANG ,
  • Guangli WANG ,
  • Wei ZHOU ,
  • Wei LI ,
  • Li QIU ,
  • Tingming LI ,
  • Quan LIU ,
  • Ping XIA ,
  • Lina MAO ,
  • Danlin YANG ,
  • Lu YANG ,
  • Fengmei LIAN ,
  • Xiaolin TONG ,
  • Yuanming BA
Expand
  • 1 Department of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
    2 Department of Infectious Diseases, Wuhan No.7 Hospital, Wuhan 430071, China
    3 Department of Electrocardiograms, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430061, China
    4 Department of Orthopaedics, Wuhan No.1 Hospital, Wuhan 430061, China; Department of Respiratory, Wuhan No.1 Hospital, Wuhan 430061, China
Prof. BA Yuanming, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430061, China. 1723426138@qq.com. Telephone:+86-27-87748195; +86-13986179621
Prof. TONG Xiaolin, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing 100053, China. tongxiaolin66@sina.com;

Received date: 2022-01-26

  Accepted date: 2022-04-12

  Online published: 2023-01-10

Supported by

A Randomized, Double Blinded, Controlled, Multicenter Clinical Trial to Improve the Symptoms of Pulmonary and Cardiac Function During the Convalescence of COVID-19(2020ZYLCYJ08-3);National Key R&D Program(2020YFC0845000);The State Administration of Traditional Chinese Medicine Special Project of Chinese Medicine Emergency Response to New Coronavirus Pneumonia(2020ZYLCYJ04-1)

Fold

Cite this article

Yuehong ZHANG , Dandan DONG , Youqin YAN , Hao ZHANG , Guangli WANG , Wei ZHOU , Wei LI , Li QIU , Tingming LI , Quan LIU , Ping XIA , Lina MAO , Danlin YANG , Lu YANG , Fengmei LIAN , Xiaolin TONG , Yuanming BA . Effectiveness and safety of Jinshuibao capsules (金水宝胶囊) in treatment of residual cardiopulmonary symptoms in convalescent patients of coronavirus disease 2019: a pilot randomized, double-blind, placebo-controlled clinical trial[J]. Journal of Traditional Chinese Medicine, 2023 , 43(1) : 134 -139 . DOI: 10.19852/j.cnki.jtcm.2023.01.012

References

1 Liu HQ, Yuan B, An YW, et al. Clinical characteristics and follow-up analysis of 324 discharged COVID-19 patients in Shenzhen during the recovery period. Int J Med Sci 2021; 18: 347-55.
2 Sonnweber T, Sahanic S, Pizzini A, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J 2021; 57: 2003481.
3 Tian FN, Ke J, Chen J, et al. Investigation and analysis of Traditional Chinese Medicine symptoms during recovery period in patients with COVID-19. Yi Yao Dao Bao 2020; 39: 637-9.
4 Fricke-Galindo I, Falfán-Valencia R. Pharmacogenetics approach for the improvement of COVID-19 treatment. Viruses 2021; 13: 413.
5 Kheirabadi D, Haddad F, Mousavi-Roknabadi RS, Rezaeisadrabadi M, Dehghan H, Fazlzadeh A. A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic. J Med Virol 2021; 93: 2705-21.
6 Wang LY, Cui JJ, OuYang QY, et al. Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude. EPMA J 2021; 12: 307-24.
7 Ren JL, Zhang AH, Wang XJ. Traditional Chinese Medicine for COVID-19 treatment. Pharmacol Res 2020; 155: 104743.
8 Zhao Z, Li Y, Zhou L, et al. Prevention and treatment of COVID-19 using Traditional Chinese Medicine: a review. Phytomedicine 2021; 85: 153308.
9 Lu Q, Li C, Chen W, Shi Z, Zhan R, He R. Clinical efficacy of Jinshuibao capsules combined with angiotensin receptor blockers in patients with early diabetic nephropathy: a Meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med 2018; 2018: 6806943.
10 Liu Y, Wang J, Wang W, Zhang H, Zhang X, Han C. The chemical constituents and pharmacological actions of Cordyceps sinensis. Evid Based Complement Alternat Med 2015; 2015: 575063.
11 Zhong LP. Discussion on the clinical application and mechanism of action of Jinshuibao. Shi Yong Lin Chuang Yi Xue 2001; 2: 99-100.
12 Das G, Shin HS, Leyva-Gómez G, et al. Cordyceps spp: a review on its immune-stimulatory and other biological potentials. Front Pharmacol 2020; 11: 602364.
13 Yan J, Zhang XY, Liu R. Research progress on the clinical application and pharmacological effect of Jinshuibao capsule. Zhong Guo Lin Chuang Yao Li Xue 2019; 35: 406-8.
14 General Office of the National Health Commission. Diagnostic and treatment of COVID-19 guideline (provisional version 7). Xin Fei Xue Guan Bing Za Zhi 2020; 39: 103-7.
15 Wenke Z, Junhua Z, Fengwen Y, et al. To treat the respiratory disease of novel coronavirus infection from dampness theory. Zhong Yi Za Zhi 2020; 61: 1024-8.
16 Jia XH, Jiang TS, Zhang B, et al. Traditional Chinese Medicine treatment for COVID-19 in recovery stage. Shandong Zhong Yi Za Zhi 2020; 39: 897-902.
17 Li XG, Chen Q, Huang MY, Fan FS, Mei LH. Advances in pharmacology of Jinshuibao capsule. Jiangxi Zhong Yi Xue Yuan Xue Bao 2000; 12: 143-4.
18 Wang Y, Kuang JL. The effects of Jinshuibao on airway remodeling, airway inflammation and oxidative stress level in asthmatic rats. Jiangxi Yi Xue Yuan Xue Bao 2009; 49: 27-31.
19 Liu XP, Chen DM, Zhang SL, Sun YH. The influence of cordyceps sinensis (Berk.) sacc. and its cultured mycelia on murine platelets and immune organs after irradiation with 60Co γ-rays. Zhong Yao Tong Bao 1988; 13: 44-6.
20 Weng BX. Clinical observation on prevention of recurrence of chronic bronchitis by Jinshuibao in 80 cases. Zhong Guo Shi Yong Yi Yao 2010; 5: 128-9.
21 Huang YL. Effect of Jinshuibao capsule on immunoglobulin of chronic obstructive pulmonary disease. Zhong Guo Zhong Yi Ji Zheng 2009; 18: 1589.
Options
Outlines

/

〈 〉